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Abstract
Background: Surgical management of renal secondary hyperparathyroidism (sHPT) is varying. Total parathyroidectomy
with heterotopic autotransplantation (TPTX + AT) is one of the standard surgical procedures in sHPT, but there is no
consensus about the optimal site for graft insertion. At the surgical department of the University Hospital of Heidelberg
we prefer the autotransplantation into the tibialis anterior muscle. The aim of this study was to assess the long-term
function of the auto-transplanted parathyroid tissue in this type of surgical procedure.
Methods: The function of the autograft of 42 patients was assessed 8.2 ± 2.5 years after surgery, using a modified
Casanova-test of the leg bearing the parathyroid tissue. Ischemic blockage was induced by tourniquet and the
levels of parathyroid hormone (PTH) were assessed during the test.
Results: At the point of assessment, the ischemic blockage led to a significant reduction in the concentration of PTH
(≥50 % of the baseline value) in 19 patients (45 %) indicating well-functioning autografts. In 11 patients (26 %), ischemic
blockage did not cause any change in the concentration of PTH (≤20 % of the baseline value), indicating functioning
residual parathyroid tissue from another site. The source of PTH production was classified as unidentifiable in five patients
(12 %). Two patients had developed graft-dependent recurrent HPT (5 %) without therapeutic consequences and three
patients suffered from persistent symptomatic hypoparathyroidism (7 %).
Conclusions: These results indicate that TPTX + AT into the tibialis anterior muscle is a successful surgical treatment for
renal HPT and that the modified Casanova-test is a suitable diagnostic tool for autografts function.
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Background
Secondary hyperparathyroidism (sHPT) is a frequent
complication of chronic renal insufficiency (CRI), espe-
cially end-stage renal disease (ESRD) [1, 2]. Advances in
the medical treatment of sHPT have reduced the need for
surgery, however 5–10 % of patients still require parathy-
roidectomy [2–4]. Surgical management of sHPT is vary-
ing [2, 3]. It can be performed using either subtotal
parathyroidectomy or total parathyroidectomy (TPTX)
with or without autotransplantation (AT) [2, 3, 5, 6]. AT
of parathyroid grafts into the sternocleidomastoid muscle
[7, 8] or the subcutaneous abdominal adipose tissue have
been widely used [9], however Wells et al. have demon-
strated that the forearm muscle can be more advantageous
[10–12]. Subcutaneous pre-sternal transplantation [13],
subcutaneous injection or transplantation in the forearm
[14, 15] and intramuscular injection in the deltoid [16],
have also been described.
At the University Hospital of Heidelberg, the preferred
method is TPTX with AT of half of the parathyroid
gland into the (right) tibialis anterior muscle. This is to
preserve the forearm if any additional shunt replacement
and/or revision in patients with sHPT become necessary.
This method also allows further surgeries under local
anesthesia when recurrent graft-dependent HPT appears
[2, 6]. Furthermore the function of the remnant can be
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observed by a Casanova-test; which is not the case for in
patients with remnants in the neck or abdominal wall
[17, 18]. The effectiveness of this method, particularly
with respect to the location of AT, has yet to be
described.
The Casanova-test was developed to establish graft
dependent recurrence [17, 19]. A simplified version of
the test, without intravenous regional analgesia (SCAT),
has been shown to distinguish the site of recurrence in
90 % of patients, when comparing to the measurement
of parathyroid hormone (PTH) levels at 10 min of supra-
systolic exclusion of the grafted arm to preischemic
values [18].
Currently, there is no accepted standard for either the
optimal site of AT or for defining a fully functional auto-
graft. The objective of this study is to evaluate the feasi-
bility of the new AT site and determine the function of
the parathyroid autografts by means of the modified
Casanova-test.
Methods
Study design and study population
Between 2002 and 2010, AT of parathyroid tissue into the
tibialis anterior muscle was the standard approach applied
in renal patients who were undergoing parathyroidectomy
at the University Hospital of General, Visceral and Trans-
plantation Surgery of Heidelberg, Germany. Forty-two
patients after TPTX with AT into the tibialis anterior
muscle were retrospectively examined on average 8.2 ±
2.5 years after surgery. Patients with primary hyperpara-
thyroidism or recurrent/ persistent disease and patients
under 18 years of age were not considered for enrollment.
The study population consisted of 26 men (mean age
50.5 ± 12.4 years) and 16 women (mean age 56.1 ±
11.6 years). Until surgery all patients received maximum
conservative therapy (vitamin D and/or analogues and
phosphate binders) and only five patients received calcimi-
metic agents (cinacalcet). At presentation one third of the
patients were still on dialysis. Written informed consent
for participation in the study and publication of acquired
data was obtained from all study patients. Ethics approval
was provided by the ethics committee of the medical
faculty of the University of Heidelberg (Ethics Approval
Number S-169/2011).
Surgical procedure
After removal of all identified parathyroid glands, half of
the smallest (0,2–0,5 cm) and most physiological -not
hyperplastic- appearing gland was carefully comminuted
into 1 mm-thick pieces. After incision in the right lower
leg (2 cm), an avascular pocket was created in the tibialis
anterior muscle and the pieces of the parathyroid gland
were implanted in all 42 patients, marked with a clip,
and the muscle pocket was closed with a suture.
Additional cervical thymectomy was performed in 13 pa-
tients (total or partial); total or subtotal thyroidectomy in
five patients and both in one patient. Final histology re-
ports revealed the presence of four parathyroid glands in
36 patients (86 %), three glands in five patients and two
glands in one patient. The most common complication
was mild postoperative hypocalcemia (mean 1.90 ±
0.15 mmol/l) in 22 patients (52 %). Other complications
observed included hungry-bone syndrome (three patients,
7 %), hyperthyroidism (two patients, 5 %), and transient
partial recurrent laryngeal nerve palsy (two patients, 5 %).
Casanova-test
Modified Casanova-test was performed as previously
described [17–19]. A Visomat comfort Typ 2040 blood
pressure cuff (UEBE Medical GmbH, Wertheim, Germany)
was used to measure systemic blood pressure at the left
upper arm. After padding the right upper leg with cot-
ton wool, a pneumatic tourniquet (Welch Allyn large
adult Nr.12 durable blood pressure cuff or ERKA per-
fect aneroid extra large cuff ) was placed. The tourni-
quet was inflated between 30 and 50 mmHg over the
systolic blood pressure. Lack of pulse of the lower limb
was assessed. Ischemia of the lower limb was main-
tained for 15 min. Blood samples were obtained from
the arm before the ischemic period, during the ischemic
period (at 5; 10; 15 min) and 10 min after deflating the
tourniquet. Intact parathyroid hormone was assessed
using the sandwich ELISA (Advia Centaur XP; SIEMENS,
Germany). The source of PTH secretion was defined
according to the time course of the PTH-levels during
ischemia, as previously suggested by Casanova et al. [17].
In brief, a PTH decrease of more than 50 % of the pre-
ischemic value (test positive) indicates the source at the
tibia, whereas a PTH decrease of less than 20 % of the
pre-ischemic value (test negative), indicates the neck or
mediastinum. A PTH decrease more than 20 % and less
than 50 %, indicates an undefined source of PTH
secretion.
All patients underwent additional ultrasonography of
the neck and the lower limb, electrocardiography and ven-
ous blood sampling (calcium, phosphate, alkaline phos-
phatase, albumin, creatinine, urea, thyroid hormones). A
99mTc-sestamibi scintigraphy was not performed as all
patients were asymptomatic and showed low PTH levels.
Clinical definitions
Hypocalcemia was defined as a serum calcium level less
than 2.1 mmol/l (normal range: 2.1–2.65 mmol/l), severe
hypocalcemia was defined as serum calcium less than
1.75 mmol/l with associated symptoms. Severe hypercal-
cemia was defined as serum calcium levels more than
3.0 mmol/l. Elevated PTH was defined as PTH levels
higher than 7.6 pmol/l (normal range: 1.3–7.6 pmol/l)
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without therapeutic consequences. Recurrent HPT was
defined as PTH levels higher than the Kidney Disease
Outcomes Quality Initiative (KDOQI) recommended
levels ca. 6 months after surgery [20]. Biochemical hypo-
parathyroidism was defined as insignificant/undetected
PTH levels (PTH ≤ 0.3 pmol/l).
Statistics
Statistical analysis was performed using the t-test of
unpaired data (Mann–Whitney t-test) and/or the Chi-
square test with GraphPad Prism 5 (GraphPad Software
Inc., La Jolla, USA). Significance was defined as p < 0.05.
Results
At the time of examination (in average 8.2 years after
surgery), 20 patients had normal PTH levels (48 %,
mean 3.6 ± 1.9 pmol/l), eight patients had a mild hypo-
parathormonemia (19 %, mean 0.8 ± 0.4 pmol/l) and
seven patients had a biochemical hypoparathyroidism
(17 %). Among those patients with biochemical hypo-
parathyroidism, three had typical symptoms of hypocal-
cemia (7 %), but were normocalcemic under daily
substitution of calcium and vitamin D. Three patients
had a recurrent HPT (7 %) according to the KDOQI-
recommended PTH levels [20]. This included two
patients after kidney transplantation and one patient on
hemodialysis; all three patients were normocalcemic
and had no typical signs and symptoms of HPT (gener-
alized bone and muscle pain, numbness, spontaneous
fractures, fatigue, mental status changes, pruritus,
nephrolithiasis). The former had double the upper
KDOQI-recommended PTH levels (66.1 pmol/l) and
was the only patient who demonstrated a sonographic
enlarged and palpable parathyroid transplant in the
tibialis anterior muscle. This patient refused surgical
reexploration. The need for therapeutic intervention
was stated after the KDOQI criteria or symptoms caus-
ing discomfort for the patient. The dose of vitamin D
was adjusted and the patients were referred to follow
up in the nephrology department. To date there has
been no need for revision.
PTH levels showed a significant decrease after surgery
(preoperative 84.0 ± 56.2 pmol/l vs. postoperative 1.4 ±
2.4 pmol/l, p < 0.0001).
Of the 42 patients, 25 were normocalcemic (60 %,
mean 2.34 ± 0.14 mmol/l) and 15 were slightly hypocal-
cemic (36 %, mean 1.88 ± 0.10 mmol/l). One patient had
a mild hypercalcemia (2 %, 2.71 mmol/l) and one a
severe hypocalcemia (2 %, 1.63 mmol/l) with normal
PTH levels and without typical symptoms.
Calcium levels also showed a significant decrease after
surgery (preoperative 2.60 ± 0.24 mmol/l vs. postopera-
tive 2.11 ± 0.34 mmol/l, p < 0.0001) (Tables 1 and 2).
In conclusion, TPTX with AT into tibialis anterior
muscle was successful in 86 % of the patients regarding
PTH levels and 96 % regarding calcium levels.
Modified Casanova-test
The modified Casanova-test was well tolerated by all
patients with some reporting a feeling of numbness and
mild pain during the ischemic time, and was discontin-
ued in 3 patients after 10 min (7 %). No other side
effects were reported.
The source of PTH secretion was assessed by compar-
ing PTH values at 15 min of ischemia (or at 10 min
when the former were not available) to the pre-ischemic
values. 19 patients (45 %) had a significant drop in PTH
(≥50 %); 11 patients (26 %) had a PTH drop of ≤20 % of
pre-ischemic value. The source of PTH was classified as
unidentifiable (PTH drop >20 % but <50 %) in five
patients (12 %). No meaningful results were observed for
seven patients with undetectable PTH levels (Fig. 1).
The 50 %-drop in PTH that classified the parathyroid
autograft as the source of the PTH secretion was obtain-
able with 95 % accuracy (in 18 of the 19 patients) after
10 min of temporary ischemic blockage.
Among the 19 patients that were positive for
Casanova-test, 10 patients had normal PTH levels, as a
sign for an intact graft function; four patients had higher
than normal PTH levels (only two higher than the
KDOQI recommended levels), indicating that the auto-
graft was the dominant source of the elevated PTH; five
patients had lower than normal PTH levels, suggesting a
limited graft function. When blood flow was restored
PTH levels increased up to basal values.
Among the 11 patients that were negative for
Casanova-test, seven patients had normal PTH levels, as
a sign for remaining parathyroid tissue or an accessory
parathyroid gland in the neck/mediastinum; two patients
had PTH levels higher than normal (only one patient
higher than the recommended KDOQI levels) indicating
the dominant source of the elevated PTH to be cervical/
mediastinal. Two patients had PTH levels lower than
normal, suggesting an insufficient PTH secretion of an
in-situ parathyroid gland in the neck/ mediastinum.
Among these 11 negative Casanova-tests, three patients
had undergone a limited parathyroidectomy of less than
four glands, three patients had undergone a partial and
two a total thymectomy.
In the remaining five cases (unpredictable source of
PTH secretion), three patients had normal PTH levels,
one patient had PTH levels higher than normal but not
higher than the recommended KDOQI levels and one
patient had PTH levels lower than normal. The inter-
mediate drop of PTH indicates functioning residual cer-
vical/mediastinal glands additional to an active autograft.
Among these five undefined Casanova-test results, no
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Table 1 Clinical and biochemical data of the study population
No Calcium prior
to surgery
(mmol/l)
PTH prior to
surgery
(pmol/l)
Calcium at
presentation
(mmol/l)
PTH at
presentation
(pmol/l)
Creatinine at
presentation
(mg/dl)
Casanova-Test
prediction
PTX (number
of glands)
Transcervical
thymectomy
Time after
PTX (months)
Dialysis
1 2.40 147 1.89 0.9 1.4 N 4 half 132 No
2 2.52 78.2 1.96 25.2 10.5 U 4 half 48 Yes
3 2.48 27.2 2.33 66.1 6.1 P 3 No 120 Yes
4 2.81 143.9 1.93 4.9 6.5 U 4 No 96 Yes
5 2.57 60.6 2.47 1.8 12.2 P 4 No 48 Yes
6 2,37 17.5 1.90 3.3 8.5 P 4 Yes 84 Yes
7 2.92 149.8 2.62 <0.1 6.1 M 4 Yes 72 Yes
8 2.70 22.4 1.90 2.3 0.9 P 4 No 120 No
9 2.69 15.5 2.29 3.9 1.3 P 4 No 132 No
10 2.73 41.8 1.89 1.6 1.4 U 4 Yes 84 No
11 2.74 56 2.15 10.4 9.1 N 3 half 72 Yes
12 2.44 63.4a 2.21 2.7 1.2 N 4 No 96 No
13 2.84 78.1 2.36 2 6.9 P 4 No 84 Yes
14 2.60 55.6 2.40 1.4 1.7 P 5 No 132 No
15 2,59 34.7 2.46 8.7 1.3 N 4 Yes 84 No
16 2.53 88.5 1.63 1.6 2.6 P 4 No 120 No
17 2.38 85.5 1.87 <0,1 1.9 M 4 No 132 No
18 2.84 84 1.77 0.7 1.2 P 4 No 72 No
19 2.48 48.3 1.87 <0.1 1.2 M 4 No 144 No
20 2.74 32.5 2.18 16.3 2.5 P 4 No 132 No
21 2.78 25.7 2.37 1.1 1.5 U 4 No 132 No
22 2.45 145.4 2.34 5.5 3 N 3 No 120 No
23 1.86 116.5 1.81 5.5 4.4 N 4 No 96 Yes
24 2.77 50.9 2.46 <1.0 6.1 N 4 No 60 Yes
25 2.76 17.4 2.44 7.7 1.7 P 4 Yes 72 No
26 1.93 129.5 2.47 3.3 5.9 N 4 No 60 Yes
27 2.64 126.3 2.30 <0.1 1.3 M 4 No 96 No
28 1.96 139.4 2.10 <0.1 2.7 M 4 Yes 72 No
29 2.57 33.5 2.36 1.4 1.3 P 3 Yes 144 No
30 2.84 23.8 2.27 5.1 1.9 P 2 Yes 72 No
31 2.64 74.7a 2.28 2 2.4 N 4 No 84 No
32 2.71 130 2.16 0.1 2.8 M 4 No 132 No
33 2.64 137 1.95 6.6 6 N 4 half 120 Yes
34 2.79 16 2.02 7 0.9 N 3 Yes 108 No
35 2.56 171 1.96 0.4 1.9 P 4 No 132 No
36 2.38 55.2a 1.91 1.2 1.2 P 4 Yes 84 No
37 2.66 18.3a 2.71 <0.3 2.4 M 4 No 48 No
38 2.72 164 2.15 15.6 9.1 P 4 No 120 Yes
39 2.82 52.1 2.45 5.5 1.2 U 4 No 72 No
40 2.81 69.1a 2.59 1.2 7.6 P 4 half 48 Yes
41 2.85 249.6 1.98 0.5 1.3 P 4 half 120 No
42 2.60 79.7 2.26 4.4 1.1 P 4 No 108 No
PTX parathyroidectomy, PTH intact parathyroid hormone, apatients receiving cinacalcet before surgery, P positive = PTH decrease of more than 50 % of the
pre-ischemic value, N negative = PTH decrease of less than 20 % of the pre-ischemic value, U source of PTH unpredictable = PTH decrease more than 20 %
and less than 50 % of the pre-ischemic value, M Casanova-test meaningless, rej. rejection of the transplant, comb combined pancreas and kidney transplant
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patient had undergone a limited parathyroidectomy of
less than four glands, one patient had undergone a
partial and one a total thymectomy.
In conclusion, 57 % of the patients had a functioning
autograft according to the Casanova-test.
Discussion
Parathyroid autotransplantation has been recorded in
the modern scientific literature since the beginning of
the 20th century [21]. Definitive evidence that trans-
planted parathyroid glands function was gathered by
Wells et al. [10], who introduced the parathyroid auto-
transplantation into the forearm [11]; this approach such
as other AT sites have been favored ever since [7, 9].
In this study, based on our traditional understanding
of the key features in successful parathyroid autografting
in sHPT, the tibialis anterior muscle was shown to be a
novel viable site of AT of the parathyroid tissue after
TPTX. Autotransplantation into the tibialis anterior
muscle was successful in 86 % of the patients with
respect to PTH levels and 96 % regarding calcium levels.
17 % of the patients had postoperative biochemical
hypoparathyroidism, however only 7 % were symptom-
atic and only 2 % suffered from severe hypocalcemia.
This is comparable to previous studies which have
reported the rate of hypoparathyroidism in 30 % after
TPTX + AT, when gland was transplantated to other
sites than tibialis anterior muscle [22].
As the remaining vital parathyroid tissue stays exposed
to the same pathophysiological environment, graft-
dependent recurrent disease is a common complication
after TPTX with AT, resulting in further diagnostic tests
and reoperative explorations. Recurrence has been reported
in 4 to 30 % of patients in recent studies and 45 to 80 % of
patients in older studies [2, 5, 23–26], although the risk of
recurrence may be minimized by selecting the appropriate
tissue [3, 22, 27–29]. Tominaga et al. reported a graft-
dependent recurrence of 17.4 % in a study cohort of
2660 patients [30]. In the current study, only 5 % of the
patients developed graft-dependent recurrent HPT ac-
cording to the KDOQI recommended PTH levels [20],
however without therapeutic consequences.
The assessment of graft function by PTH blood sam-
pling is routinely reported in the literature [2, 4–6, 15], as
is calcium levels [2, 31]. However both methods cannot be
used to assess the presence of a supernumerary gland or
ectopic parathyroid tissue. Only one study has attempted
to examine the actual parathyroid autograft function using
Table 2 Outcome of parathyroidectomy with autotransplantation into the tibialis muscle
Number of patients
Preoperative Intraoperative Postoperative Follow up
Hypopara (PTH ≤0.3 pmol/l) 0 17 7
Reduced PTH (PTH >0.3 - <1.3 pmol/l) 2 8 8
Eupara (PTH 1.3-7.6 pmol/l) 19 10 20
Elevated PTH (PTH >7.6 pmol/l) 42 21 2 4
Hyperpara according KDOQI [20] 3
Mean PTH (range 1.3-7.6 pmol/l) 84.0 ± 56.2 10.6 ± 9.1 1.38 ± 2.4 5.42 ± 10.9
Mean Calcium (range 2.1-2.65 pmol/l) 2.60 ± 0.2 Nodata 2.1 ± 0.3 2.17 ± 0.3
PTH intact parathyroid hormone
Fig. 1 Casanova-Test and source of parathyroid hormone. Casanova-Test results show a positive Casanova-Test (PTH decrease of more than 50 % of the
pre-ischemic value) in 19 patients (45 %, source of PTH: autograft), a negative Casanova-Test (PTH decrease of less than 20 % of the pre-ischemic value)
in 11 patients (26 %, source of PTH: neck), an unpredictable Casanova-Test (PTH decrease more than 20 % and less than 50 % of the pre-ischemic value)
in 5 patients (12 %, source of PTH unidentifiable: neck or autograft) and a pointless Casanova-Test (pre-ischemic value of PTH≤ 0.3 pmol/l) in 7 patients
(17 %, biochemical hypoparathyroidism). PTH: intact parathyroid hormone; Hypopara: biochemical hypoparathyroidism
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the Casanova-test [19]. The autograft function may be also
indirectly assessed by measuring the level of PTH in sera
from the antecubital veins of the grafted and nongrafted
arms, with a PTH ratio of 1.5 or greater indicating func-
tional parathyroid tissue [14, 32]. The percentage uptake
of parathyroid tissue autografts using Wells’ method has
been reported to range from 35 to 96 % [32–35]. The per-
centage uptake of subcutaneously or intramuscular injected
parathyroid tissue is comparable (69–90 %), however in a
relatively short follow-up period [13, 14, 16]. In the current
study, 57 % of the patients had a functioning autograft in a
long-term follow-up according to the Casanova-test; 26 %
of the patients had a satisfactory PTH secretion without a
positive Casanova-test, indicating active remaining parathy-
roid tissue within the neck/mediastinum.
Besides allowing easy surgical access and simple test-
ing, the implantation of parathyroid tissue into the
lower limb could be advantageous as compared to the
forearm, since in dialysis patients the anatomy of the
forearms is often changed due to arteriovenous fistula
(AVF) operations [36, 37]. In addition, surgical revision
of the fistulas or replacement with a graft, which is
necessary in cases of AVF failure, stenosis, dysfunction
or occlusion, could be more complicated after auto-
transplantation of parathyroid tissue. Early AVF failure
is common, with an incidence in the range of 20 to
60 % [38, 39]. The tibialis anterior muscle is a relatively
large and resistant muscle and therefore enables wide
excisions without sacrificing vital structures, if infiltrat-
ing growth of parathyroid graft were to occur. Since
dialysis patients often have a difficult vascular situation,
it appears important to protect the forearm for an
additional shunt revision or replacement.
Since this study was intended as pilot study, no con-
trol group was included. A further limitation of the
study is that the surgical procedure wasn’t standardized.
Routine transcervical thymectomy was not performed.
Finally, the function of the graft might be influenced by
various factors, e.g. 33 % of patients with insufficient
PTH secretion had diabetes mellitus of which 80 %
revealed undetectable PTH levels (p <0.05). Further
studies with larger number of patient cohorts are re-
quired to confirm these data.
Conclusions
Total parathyroidectomy with AT of parathyroid tissue
in the lower limb is a safe and effective therapy for
renal HPT. The autograft function could be effectively
assessed by means of the modified Casanova-test The
advantage of preserving the forearm in CRI patients
combined with the easy testing of autografts in extrem-
ities qualifies this procedure as an alternative therapy
for sHPT.
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